Distribution of invasive meningococcal B disease in Italian pediatric population: Implications for vaccination timing
Authors:
- Chiara AzzariCAChiara Azzari
- Maria MoriondoMMMaria Moriondo
- Giuseppe IndolfiGIGiuseppe Indolfi
- Paolo CastigliaPCPaolo Castiglia
- Vincenzo BaldoVincenzo Baldo
- Italian Group for the Study of Invasive Bacterial DiseaseIDItalian Group for the Study of Invasive Bacterial Disease
Open Access
- 1 February 2014
- Vol. 32 (10) , 1187-1191
Abstract
No abstract availableKeywords
Funding Information
- Italian Department of Health (CCM)
- Anna Meyer Children's University Hospital
- University of Florence
This publication has 21 references indexed in Scilit:
- Impact on disease incidence of a routine universal and catch-up vaccination strategy against Neisseria meningitidis C in Tuscany, ItalyVaccine, 2012
- Immunogenicity and Tolerability of Recombinant Serogroup B Meningococcal Vaccine Administered With or Without Routine Infant Vaccinations According to Different Immunization SchedulesJAMA, 2012
- Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled studyThe Lancet, 2012
- The Global Meningococcal Initiative: Recommendations for reducing the global burden of meningococcal diseaseVaccine, 2011
- Community‐Acquired Bacteremic Pneumococcal Pneumonia in Children: Diagnosis and Serotyping by Real‐Time Polymerase Chain Reaction Using Blood SamplesClinical Infectious Diseases, 2010
- Effect of meningitis in infancy on school-leaving examination resultsArchives of Disease in Childhood, 2007
- Long term follow up after meningitis in infancy: behaviour of teenagersArchives of Disease in Childhood, 2003
- The Epidemiology of Severe Sepsis in Children in the United StatesAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Meningitis in infancy in England and Wales: follow up at age 5 yearsBMJ, 2001
- Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of careCritical Care Medicine, 2001